1.Histone deacetylase inhibitor affected CD4+CD25+Foxp3+ cells in a mouse model of acute graftversus host disease
Chinese Journal of Tissue Engineering Research 2014;(49):7908-7913
BACKGROUND:Prevention and treatment of graftversus host disease and elevation of graft survival rate are core problems needed to be solved in alogenic hematopoietic stem cel transplantation. Thus, it is necessary to find a new immunosuppressant. Recent studies showed that histone deacetylase inhibitor has immunomodulatory effects. OBJECTIVE:To observe the effects of histone deacetylase inhibitor SAHA on acute graftversus host disease in mice and the immunomodulatory effects. METHODS: C57BL/6(H-2b)→BALB/C(H-2d) was selected as donor and recipient of complete alotransplantation. At 3, 5, 7, 9 and 11 days after transplantion, mice in the treatment group were intraperitonealy given SAHA (35 mg/kg) (0.2 mL). Mice in the control group were intraperitonealy given sterile water 0.2 mL/time. Flow cytometry, real-time quantitative PCR and pathology were used to compare the clinical manifestations, survival time and CD4+CD25+Foxp3+ cel percentage of acute graftversus host disease in mice of both groups. RESULTS AND CONCLUSION:In the treatment group, the time of acute graftversus host disease was delayed and the extent was reduced and survival time was longer compared with the control group. Survival rate was significantly higher in the treatment group than in the control group (P < 0.05). After transplantation, the proportions of CD4+CD25+Foxp3+ cels gradualy increased with prolonged time in the treatment group. On the contrary, the proportions of CD4+CD25+Foxp3+ cels gradualy decreased with prolonged time in the control group (P < 0.05). Above data suggested that SAHA delayed the occurrence of acute graftversus host disease and lessened the severity of acute graft versus host disease possibly through elevating the proportion of CD4+CD25+Foxp3+ cels.
2.Nano-hydroxyapatite artificial bone for collapsed fractures of the tibial plateau
Daping WANG ; Jianyi XIONG ; Weimin ZHU ; Jianghong HUANG ; Li DUAN ; Jielin CHEN ; Jufeng ZHANG
Chinese Journal of Tissue Engineering Research 2013;(51):8863-8868
BACKGROUND:Nano-hydroxyapatite helps to improve the mechanical properties of bone implants.
OBJECTIVE:To study the clinical effect of nano-hydroxyapatite artificial bone on col apsed fracture of the tibial plateau.
METHODS:Fourteen cases of col apsed fracture of the tibial plateau combined with bone defects from March 2010 to September 2012 were analyzed retrospectively. The bone defect range was from 1.5 cm×1.0 cm to 3.1 cm×4.5 cm. Al patients were treated with nano-hydroxyapatite artificial bone at an implant amount of 5-14 g. Clinical and X-ray observations were applied at 1 week, 1 month and 3 months postoperatively. Hospital for Special Surgery scores were employed for recovery of knee function.
RESULTS AND CONCLUSION:The patients were fol owed up for 12-27 months. Except for one case of a smal amount of wound exudates, no general side effects occurred in 13 cases. X-ray photo showed an integrity interface between nano-hydroxyapatite artificial bone and host bone at 3 months after treatment. Primary healing was obtained in al cases without any complications. Hospital for Special Surgery score was increased to (88.7±4.3) points at 1 year later. These findings indicate that the nano-hydroxyapatite artificial bone has a good biocompatibility and biomechanics, and it may be an ideal artificial bone for repairing col apsed fractures of the tibial plateau.
3.Study of the difference of high and low metastasis cell line's gene expression map and metastasis-related genes of adenoid cystic carcinoma.
NaiShuo ZHU ; JieLin YANG ; YingMing WANG ; XiaoFeng GUAN
Experimental & Molecular Medicine 2003;35(4):243-248
We searched for metastasis-related genes in adenoid cystic carcinoma by suppression subtractive hybridization analysis of high and low metastasis cell lines. Twelve genes (ten previously identified and two novel sequences) were identified as being expressed at lower levels in high metastasis cell line Acc-M when compared to low metastasis cell line Acc-2. The known sequences corresponded to the genes for cysteine-rich angiogenesis induction factor (cyr61), chromosome 7 RP11-52501 clone, G-protein, WAS familial ferritin I heavy chain, jumping translocation breakpoint, eukaryotic translation elongation, folate receptor and three ribosomal proteins. Among them, the G protein and ferritin I heavy chain genes contained mutations in the high metastasis cell line. The two novel gene sequences have been named ACC metastasis-associated RNH and ACC metastasis-associated suspected protein (GenBank # AF522024 and AF522025, respectively). Taken together, these results suggest that reduced expression and/or mutation of several genes in the tumor cell line Acc-M are associated with high tumor metastasis, providing important molecular biological materials for further study of metastasis control and possible targets for cancer gene therapy.
Blotting, Northern
;
Carcinoma, Adenoid Cystic/*genetics/secondary
;
*Gene Expression
;
Gene Expression Profiling
;
Gene Expression Regulation, Neoplastic
;
Human
;
In Vitro
;
Molecular Sequence Data
;
Neoplasm Metastasis/*genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Tumor Cells, Cultured
4.Recent advances in research on chelators as metallo-β-lactamase inhibitors
Zhixi ZHU ; Jielin ZHANG ; Yijun CHEN
Journal of China Pharmaceutical University 2022;53(4):410-422
The major reason for the resistance of Gram-negative bacteria to β-lactam antibiotics is the expression of β-lactamases.Metallo-β-lactamases (MBL) hydrolyze almost all types of β-lactam antibiotics including carbapenems, posing a challenge to global public health. Developing MBL inhibitors is an important method to treat the infections caused by resistant bacteria. As an important type of MBL inhibitors, chelating agents can inhibit MBL by chelating, stripping, and binding Zn2+ in the active center of MBL.This review summarizes recent publications on chelators as MBL inhibitors, discussing their chemical structures, inhibitory potency, synergistic effects with antibiotics, selectivity and mechanism of action, including EDTA and related compounds, aspergillomarasmine A (AMA) and its derivatives, NOTA and related compounds, pyridine carboxylic acid and pyridine methylamine compounds, aiming to provide reference for future development of potent, selective and safe clinical MBL inhibitors.
5.Study of the distribution of KIR3DL2 alleles among ethnic Han Chinese from Zhejiang.
Chen CHEN ; Jielin WANG ; Yanmin HE ; Sudan TAO ; Ji HE ; Faming ZHU
Chinese Journal of Medical Genetics 2021;38(6):589-592
OBJECTIVE:
To study the distribution of KIR3DL2 alleles among ethnic Han Chinese from Zhejiang.
METHODS:
Genomic DNA was extracted by using a magnetic bead method. The full sequence of the KIR3DL2 gene was amplified with four pairs by PCR primers. The coding regions of 208 unrelated ethnic Han Chinese blood donors were analyzed using a BigDye Terminator v3.1 Sequencing Kit. The genotypes were assigned based on the nucleotide polymorphism of the KIR3DL2 gene.
RESULTS:
Among the 208 samples, 133 were KIR3DL2 heterozygotes and 75 were homozygotes. Forty six KIR3DL2 genotypes were detected. Respectively, 70, 33 and 23 individuals were found to have a KIR3DL2*00201/KIR3DL2*00201, KIR3DL2*00201/KIR3DL2*00701, and KIR3DL2*00201/KIR3DL2*01001 genotype. Twenty-two KIR3DL2 alleles were discovered, and the frequencies of KIR3DL2*00201, KIR3DL2*00701 and KIR3DL2*01001 were 57.45%, 13.46% and 9.13%, respectively.
CONCLUSION
The distribution of KIR3DL2 alleles among ethnic Han Chinese in Zhejiang has been determined and fits the criteria for genetic polymorphism.
Alleles
;
China
;
Ethnic Groups
;
Gene Frequency
;
Humans
;
Polymorphism, Genetic
;
Receptors, KIR3DL2